Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 21 | 54 | 71 | 58 |
| Receivables | 6 | 23 | 0 | 0 | 3 |
| TOTAL | $218 | $262 | $207 | $230 | $221 |
| Non-Current Assets | |||||
| Intangibles | 239 | 261 | 236 | 251 | 253 |
| TOTAL | $239 | $261 | $236 | $251 | $253 |
| Total Assets | $456 | $522 | $444 | $480 | $474 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,446 | 3,714 | 3,008 | 2,600 | 1,286 |
| TOTAL | $3,706 | $3,964 | $3,224 | $2,752 | $1,286 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 145 | 156 | 0 | 0 | 0 |
| TOTAL | $145 | $156 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,852 | $4,120 | $3,224 | $2,752 | $1,286 |
| Shareholders' Equity | |||||
| Common Shares | 11,679 | 12,264 | 10,955 | 11,450 | 11,381 |
| Retained earnings | -17,256 | -18,170 | -15,728 | -15,949 | -14,526 |
| Other shareholders' equity | 2,182 | 2,308 | 1,993 | 2,227 | 2,334 |
| TOTAL | $-3,395 | $-3,597 | $-2,781 | $-2,272 | $-812 |
| Total Liabilities And Equity | $456 | $522 | $444 | $480 | $474 |